Huijun Ouyang

Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event

Carolyn S.P. Lam, Anna Giczewska, Karen Sliwa et al. · JAMA Cardiology · 2020 · 82 citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial

Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom et al. · The Lancet · 2025 · 64 citations · Full text

Medicine, Cardiology, Internal Medicine +12

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

Faı̈ez Zannad, Christopher M. O’Connor, Javed Butler et al. · The Lancet · 2025 · 32 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

Development and validation of a prognostic nomogram for myocardial infarction patients in intensive care units: a retrospective cohort study

Qi Guo, Maoxiong Wu, Hongwei Li et al. · BMJ Open · 2020 · 25 citations · Full text

Medicine, Cardiology, Critical Care Cardiology +12

Heart Rate Fluctuation and Mortality in Critically Ill Myocardial Infarction Patients: A Retrospective Cohort Study

Qi Guo, Hongwei Li, Huijun Ouyang et al. · Frontiers in Cardiovascular Medicine · 2021 · 11 citations · Full text

Medicine, Cardiology, Internal Medicine +11